These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 2938321

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The implications of HLA-DR match for the outcome of cadaveric renal transplantation.
    Berg B, Groth CG, Klintmalm G, Lundgren G, Möller E.
    Scand J Urol Nephrol Suppl; 1980; 54():29-31. PubMed ID: 7013037
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Evaluation of the effects of cyclosporine and HLA-typed source leukocyte transfusions (apheresis by-products) on the immune systems of highly sensitized prospective renal allograft recipients.
    Weir MR, Shen SY, Dagher FJ, Bentley FR, Lesko L, Sadler JH.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):735-7. PubMed ID: 3547838
    [No Abstract] [Full Text] [Related]

  • 50. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin.
    Lundgren G, Groth CG, Albrechtsen D, Brynger H, Flatmark A, Frödin L, Gäbel H, Husberg B, Klintmalm G, Maurer W.
    Lancet; 1986 Jul 12; 2(8498):66-9. PubMed ID: 2873380
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Correlation of MLC response with graft survival in cadaver and related donor kidney transplants.
    Walker J, Opelz G, Terasaki PI.
    Transplant Proc; 1978 Dec 12; 10(4):949-51. PubMed ID: 153621
    [No Abstract] [Full Text] [Related]

  • 54. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF, de Lange P, Persijn GG, van Rood JJ.
    Transplant Proc; 1987 Feb 12; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract] [Full Text] [Related]

  • 55. [Immunologic selection of donors and recipients in renal graft: transplantation antigens ].
    Seignalet J, Mourad G, Mion C.
    Nephrologie; 1982 Feb 12; 3(2):73-9. PubMed ID: 6750427
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effect of prospective matching for HLA-DR on renal allograft survival in a single center.
    Goeken NE, Thompson JS, Corry RJ.
    Transplantation; 1981 May 12; 31(5):397-9. PubMed ID: 7015630
    [No Abstract] [Full Text] [Related]

  • 59. Cyclosporine A and histocompatibility in kidney transplantation.
    Cook DJ, Terasaki PI.
    Transplant Proc; 1988 Jun 12; 20(3 Suppl 3):244-8. PubMed ID: 3291250
    [No Abstract] [Full Text] [Related]

  • 60. Tissue typing and the survival of renal grafts.
    Mebel M.
    Acta Med Pol; 1978 Jun 12; 19(1-2):67-9. PubMed ID: 367077
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.